Objective: With the surge in the number of entrepreneurs in the New England community of Chinese experts and scholars, Harvard Medical School Chinese Scientist and Scholars Association (HMS-CSSA) is making an effort to build a communication platform between entrepreneurs, professionals from industry and investors through the form of entrepreneurship forums. This year HMS-CSSA are inviting speakers from industry and the investment community to discuss frontiers and trends in the healthcare field. Also, we would like to provide an opportunity for young entrepreneurs in the Harvard Medical School to have in-depth thoughts from investors and successful entrepreneurs through the Business Plan Road Show. We hope this forum could help promote the transformation of biomedical research in the Greater Boston area.
Rewards for the winner of the Business Plan Road Show：
First Prize: a certificate and a cash prize
Second Prize: a certificate
Location: Folkman Auditorium, Enders Building, Children’s Hospital Boston
320 Longwood Ave, Boston, MA 02155
9:00am-9:25am: Alan Jiang, PhD, XtalPi
9:25am-9:50am: Xiaoyu Tian, PhD, Vice President of Product Development, VcanBio (中源协和)
9:50am-10:15am: Jeff Clark, JD, MD Associate at DLA Piper
Topic: Intellectual Property Protection in USA
(Taking example of the gene editing CRISPR/Cas9 patent)
10:15am-10:40am: Chesley Chen, SM, MBA, Chief Executive Officer, Safety Partners, Inc.
Topic: Zen and the Art of CEO Maintenance
10:40am-11:20pm: Panel Discussion
11:20am-13:00pm: Business Plan Road Show and Award
13:00 pm-14:00 pm: Lunch and Networking
Jeff Clark, JD, MD
(Jeff is also among those drafted the ground breaking CRISPR/Cas9 gene editing patent.)
Jeff Clark, MD, JD, is an associate at DLA Piper with a focus on patent litigation and the defense of pharmaceutical, life science and medical device companies in a variety of cases, including multi-district product liability litigation. Jeff also concentrates his practice on all aspects of patent law including patent prosecution and strategic counseling for life science start-ups, biotech, medical device and pharmaceutical companies. Jeff has extensive clinical and basic science research experience. He was a clinical research fellow in the Molecular and Vascular Medicine Unit, Renal Division (Department of Medicine), at Beth Israel Deaconess Medical Center and in the Cardiovascular Research Center (Department of Cardiology) at Massachusetts General Hospital. Jeff has authored and co-authored several publications in peer-reviewed journals and has presented at the national American Society of Nephrology Renal Week conference.
Chesley Chen, SM, MBA
Chesley Chen is Chief Executive Officer of Safety Partners, Inc., which provides environmental, health, and safety programs to over 200 life science and technology companies each year. Chen is a serial entrepreneur and brings extensive experience in launching and scaling up early to mid-stage health technology, life science, and financial service ventures. He has over 30 years experience in executive management, corporate strategy, client service, product development, operations, technology, and finance. He has worked for a wide range of firms including Health Dialog, Good Measures, The Warner Babcock Institute for Green Chemistry, and Goldman Sachs.
Chen holds a BS in Civil Engineering from Tufts University, an SM in Aeronautics and Astronautics from MIT, and an MBA from the Harvard Business School. As he continues on his career journey, he dedicates time to sharing his experiences about his path to CEO and his ongoing learnings. Outside of work, he devotes his time to family, rock climbing, martial arts, piano, and studying the arts and sciences. He is of Chinese heritage, the son and grandson of Chinese immigrants.
Alan Jiang, PhD, CSO, XtalPi
Yide Alan Jiang oversees global market positioning and strategy development at XtalPi. Dr.Jiang has 14 years of experience in biopharmaceutical R&D, with expertise in managing external translational science collaborations between academia, industry and contract research organizations. Prior to joining XtalPi, Dr. Jiang held the role of Director of Asia R&D strategy and Associate Scientific Director at Genzyme, where he led cross-functional R&D collaborations and projects in Asia and conducted external consultation for various companies on R&D strategy and processes. His completed his postdoctoral fellowship of hematology and oncology at Harvard Medical School, and has worked as project manager at China’s National Institute for the Control of Pharmaceutical and Biological Products (NICPBP, NIFDC), CFDA.
Dr. Jiang earned his PhD in molecular biology from University of Tennessee-Health Science Center and MD from Shanghai Medical University (now Shanghai Medical College of Fudan University).
Xiaoyu Tian, PhD, Vice President of Product Development, VcanBio (中源协和)
Yongjin Group (涌金集团)
Legend Capital (君联资本)
CSC Group (中科招商)
Wuxi Healthcare Venture (毓承资本)
Business Plan Calling：Please send your brief business plan (300-500 words or slides) to CSSA@HMS-CSSA.ORG before April 21st